Aetna modified CPB 0019 for Holter monitoring, effective September 26, 2025. Here's what billing teams need to know before that date.
Aetna, a CVS Health company, updated its Holter monitor coverage policy under CPB 0019 in the Aetna system. The change affects CPT codes 93224, 93225, 93226, and 93227—the full set of codes covering external electrocardiographic monitoring up to 48 hours. If your cardiology, internal medicine, or electrophysiology practice bills Aetna for continuous rhythm recording, this coverage policy update applies to you.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Holter Monitors — CPB 0019 |
| Policy Code | CPB 0019 |
| Change Type | Modified |
| Effective Date | September 26, 2025 |
| Impact Level | Medium |
| Specialties Affected | Cardiology, Electrophysiology, Internal Medicine, Endocrinology (diabetic autonomic neuropathy), Pediatric Cardiology |
| Key Action | Audit active Holter orders and claims for frequency limits and duration caps before September 26, 2025 |
Aetna Holter Monitor Coverage Criteria and Medical Necessity Requirements 2025
The Aetna Holter monitor coverage policy under CPB 0019 sets a defined list of covered indications. Aetna considers Holter monitoring medically necessary only when a patient meets one or more of the criteria below. Nothing else qualifies.
The covered indications span both adults and a narrow pediatric exception. For adult members, medical necessity applies to assessment of antiarrhythmic medication efficacy, assessment of surgical intervention efficacy for arrhythmia, autonomic cardiac neuropathy tied to diabetes mellitus, idiopathic hypertrophic or dilated cardiomyopathy, and evaluation of possible or documented long QT syndrome. Pacemaker and ICD function assessment also qualifies, as does variant (Prinzmetal's) angina, post-MI left ventricular dysfunction, and arrhythmia-related symptoms like palpitations, syncope, near-syncope, and unexplained dizziness.
The one pediatric carve-out: asymptomatic congenital complete atrioventricular (AV) block in pediatric patients is covered. This is narrow and specific. Don't let it get coded broadly.
Frequency and duration limits are where this policy bites. Aetna considers Holter monitoring medically necessary no more than twice in any six-month window. Monitoring lasting more than 48 hours is not medically necessary under this policy. Those two rules together eliminate a large category of denials before they happen—if your team documents carefully and stays inside the limits.
CPT 93224 covers the full external electrocardiographic monitoring episode up to 48 hours, 93225 covers the recording component (connection, recording, disconnection), 93226 covers scanning analysis with report, and 93227 covers physician review and interpretation. Bill all four codes accurately and in sequence. A broken code set—billing 93224 without 93227, for example—invites a claim denial.
This policy does not list a prior authorization requirement on its face. That doesn't mean your specific Aetna contract or plan is silent on prior auth. Verify at the plan level before billing. Some commercial Aetna plans layer additional utilization management on top of CPB 0019.
Reimbursement for 93224 through 93227 is contingent on satisfying the selection criteria above. No indication match, no reimbursement.
Aetna Holter Monitor Exclusions and Non-Covered Indications
Aetna is direct about this: any indication not on the covered list is experimental, investigational, or unproven. The policy states effectiveness has not been established for other uses. That's a blanket exclusion, not a gray area.
The real-world implication is that off-label Holter orders—monitoring for non-cardiac complaints, wellness screening, or vague fatigue without documented arrhythmia symptoms—will not pass Aetna medical necessity review. Your clinical documentation needs to map directly to one of the 10 covered indications.
There's also a duration exclusion baked into the policy. Monitoring beyond 48 hours is not medically necessary under CPB 0019. If the clinical picture demands longer-duration monitoring, Aetna's own policy points you toward cardiac event recorders under CPB 0073. That's not a workaround—it's the intended pathway. If your physician orders extended monitoring and you bill 93224–93227 for a 72-hour study, expect a denial.
The frequency cap reinforces this. More than two studies in a six-month period will trigger scrutiny. If your cardiologist believes more frequent monitoring is clinically warranted, the answer under this policy is cardiac event monitoring—not additional Holter studies.
Coverage Indications at a Glance
| Indication | Status | Relevant ICD-10 Codes | Notes |
|---|---|---|---|
| Assessment of antiarrhythmic medication efficacy | Covered | I47.x, I48.x, I45.x | Must document therapeutic assessment purpose |
| Assessment of surgical arrhythmia intervention efficacy | Covered | I47.x, I48.x | Post-procedure context required |
| Autonomic cardiac neuropathy — diabetic | Covered | E10.40–E10.49, E10.610, E11.40–E11.49, E11.610, G99.0 | Diabetes ICD-10 coding must be specific |
| Idiopathic hypertrophic or dilated cardiomyopathy | Covered | I42.0–I42.2, I42.5, I42.8–I42.9 | Idiopathic only — cardiomyopathy secondary to other conditions is not listed |
| Evaluation of possible or documented long QT syndrome | Covered | I45.x | Specific to QT syndrome documentation |
| Pacemaker or ICD function assessment | Covered | I44.x, I45.x | Device type must be documented |
| Variant (Prinzmetal's) angina | Covered | I20.0–I20.1 | Pain pattern documentation critical |
| Post-MI left ventricular dysfunction | Covered | I21.01–I22.9, I21.A1, I21.A9, I24.0–I24.9, I25.2 | LV dysfunction must be documented |
| Arrhythmia-related symptoms (palpitations, syncope, near-syncope, dizziness) | Covered | I47.x, I48.x, G45.x | Symptom specificity in documentation matters |
| Asymptomatic congenital complete AV block — pediatric | Covered | I44.0–I44.7 | Pediatric patients only; adults not covered under this indication |
| All other indications | Not Covered | — | Considered experimental, investigational, or unproven |
| Monitoring > 48 hours | Not Covered | — | Refer to CPB 0073 for cardiac event monitors |
| More than 2 studies in 6 months | Not Covered | — | Additional studies should use cardiac event recorder pathway |
Aetna Holter Monitor Billing Guidelines and Action Items 2025
Here's what your billing team should do before the September 26, 2025 effective date.
| # | Action Item |
|---|---|
| 1 | Audit your active Holter order queue. Pull every open or pending Holter order for Aetna members. Map each one to a covered indication from CPB 0019. Any order that doesn't match one of the 10 criteria is a future denial. Flag it for physician review now. |
| 2 | Set a frequency tracker for Aetna Holter claims. You need a way to flag any Aetna member who has already received one Holter study in the current six-month period. A second study is the limit. A third triggers a denial and a likely take-back audit. Build this into your charge capture or EHR workflow. |
| 3 | Document duration explicitly in the order. The 48-hour cap isn't a billing technicality—it's the clinical limit Aetna will hold you to. If a physician orders a Holter for more than 48 hours, stop and redirect. Route the order to cardiac event monitoring under CPB 0073 before the study starts. A completed 72-hour Holter is not recoverable for reimbursement under this policy. |
| 4 | Verify ICD-10 specificity for diabetic autonomic neuropathy cases. This is one of the less obvious covered indications. The qualifying ICD-10 codes are specific: E10.40–E10.49, E10.610 for Type 1 DM with neurological complications, and E11.40–E11.49, E11.610 for Type 2. G99.0 (autonomic neuropathy in diseases classified elsewhere) also maps. Generic diabetes codes like E11.9 won't establish medical necessity here. |
| 5 | Confirm plan-level prior authorization requirements. CPB 0019 doesn't mandate prior authorization across all Aetna plans, but individual plan contracts vary. Check your specific contract and use Aetna's NaviNet or authorization lookup before scheduling studies for high-cost Aetna commercial or Aetna Medicare Advantage members. |
| 6 | Update your Holter billing guidelines internally to reflect the September 26, 2025 effective date. Send a note to your cardiologists and ordering physicians now. A brief one-page summary of the 10 covered indications and the two hard limits—twice per six months, 48-hour maximum—prevents most of the denials before they happen. |
If you bill a high volume of Holter studies for Aetna members and you're not sure how your current utilization patterns map to these criteria, pull a 90-day claim history before September 26. If you see patterns that don't fit the covered indications, loop in your compliance officer.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Holter Monitors Under CPB 0019
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 93224 | CPT | External electrocardiographic monitoring up to 48 hours by continuous rhythm recording and storage |
| 93225 | CPT | Recording (includes connection, recording, and disconnection) |
| 93226 | CPT | Scanning analysis with report |
| 93227 | CPT | Physician review and interpretation |
Key ICD-10-CM Diagnosis Codes
| Code(s) | Description |
|---|---|
| E10.40–E10.49, E10.610 | Type 1 diabetes mellitus with diabetic neurological complications |
| E11.40–E11.49, E11.610 | Type 2 diabetes mellitus with diabetic neurological complications |
| F45.8 | Other somatoform disorders |
| F51.1–F51.9 | Sleep disorders not due to a substance or known physiological condition (if undergoing sleep studies) |
| G45.0–G45.1, G45.8–G45.9 | Transient cerebral ischemic attacks and related syndromes |
| G47.00–G47.39, G47.50–G47.9 | Sleep disorders (if undergoing sleep studies for suspected obstructive sleep apnea) |
| G99.0 | Autonomic neuropathy in diseases classified elsewhere |
| I20.0–I20.1 | Ischemic heart disease (including Prinzmetal's / variant angina) |
| I21.01–I22.9 | Acute myocardial infarction |
| I21.A1 | Myocardial infarction type 2 |
| I21.A9 | Other myocardial infarction type |
| I24.0–I24.9 | Other acute ischemic heart diseases |
| I25.2 | Old myocardial infarction |
| I42.0–I42.2, I42.5, I42.8–I42.9 | Cardiomyopathy (including idiopathic hypertrophic and dilated) |
| I44.0–I44.7 | Atrioventricular and left bundle-branch block |
| I45.0–I45.9 | Other conduction disorders |
| I46.2–I46.9 | Cardiac arrest |
| I47.0–I47.9 | Paroxysmal tachycardia |
| I48.0–I48.28 | Atrial fibrillation and flutter |
Note: Aetna's CPB 0019 includes 172 ICD-10-CM codes in total. The table above covers the primary diagnostic groupings. Verify the full code list against the current published policy at the source.
Get the Full Picture for CPT 93224
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.